Central VetPharma Consultancy ApS: Financial statements 2024
CVR: 38773984
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Central VetPharma Consultancy ApS (CVR 38773984) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,279,637 and a net result of DKK 479,115 compared with DKK 803,625 the year before. That is a decrease of 5.9% compared with the year before. Equity in the 2024 report amounted to DKK 4,374,379. The solvency ratio was 96.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,279,637
- Profit/Loss
- DKK 479,115
- Equity
- DKK 4,374,379
- Total Assets
- DKK 4,519,940
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.3M | 479K | 4.4M | 1 |
| 2023 | - | 1.4M | 804K | 4.1M | 1 |
| 2022 | - | 1.4M | -97K | 3.4M | 1 |
| 2021 | - | 1.3M | 577K | 3.6M | 1 |
| 2020 | - | 1.5M | 1M | 3.2M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Central VetPharma Consultancy ApS has published its annual report for 2023. Gross profit came to DKK 1,359,512, and the net result was DKK 803,625.
About Central VetPharma Consultancy ApS
Central VetPharma Consultancy ApS is a Danish company of the type Anpartsselskab based in Sorø, founded in 2017. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Anja Elisabeth Houlberg Holm. The company is owned by Anja Elisabeth Houlberg Holm. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,620,579 and a net result of DKK 719,033 compared with DKK 479,115 the year before. Equity in the 2025 report amounted to DKK 4,658,412.